US Bancorp
ALXO icon

US Bancorp’s ALX Oncology ALXO Stock Holding History

US Bancorp’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-65
Closed -$1K – 4138
2022
Q3 		$1K Buy
+65
New +$758 ﹤0.01% 3906
2022
Q2 		– Sell
-577
Closed -$9K – 4064
2022
Q1 		$9K Buy
577
+194
+51% +$3.31K ﹤0.01% 3391
2021
Q4 		$9K Buy
383
+74
+24% +$3.19K ﹤0.01% 3445
2021
Q3 		$23K Buy
309
+299
+2,990% +$19.9K ﹤0.01% 3053
2021
Q2 		$1K Buy
+10
New +$598 ﹤0.01% 3884

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

US Bancorp's ALXO Position: Q4 2022 in Review

US Bancorp sold out of ALX Oncology (ALXO) in Q4 2022, closing a stake of 65 shares — an estimated $1K sold.

US Bancorp first reported a position in ALXO in Q2 2021 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2022.

  • US Bancorp reported no remaining ALX Oncology position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 65 ALX Oncology shares in Q4 2022, an estimated $1K.
  • US Bancorp first reported a position in ALX Oncology in Q2 2021 and held it in 5 quarters.
  • US Bancorp's ALX Oncology position peaked at $23K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.